VREXHIGH SIGNALFINANCIAL10-K

VREX experienced a dramatic operational deterioration with operating income swinging from $32.1M profit to -$27.8M loss, representing a -186.6% decline despite gross profit growth.

This massive swing from operating profitability to significant losses indicates severe operational execution issues or major one-time charges that management will need to explain. The combination of growing gross profits but collapsing operating income suggests dramatic increases in operating expenses that could signal fundamental business model challenges or major restructuring costs.

Comparing 2025-11-18 vs 2024-11-19View on EDGAR →
FINANCIAL ANALYSIS

VREX shows a concerning mixed financial picture with gross profit growing 13.1% to $290.5M but operating income collapsing from $32.1M to -$27.8M (-186.6%), indicating severe operating expense inflation. While the company reduced total debt by 17.1% and interest expense by 26.4%, net losses deepened to -$70.3M, cash declined 14% to $145.0M, and stockholders' equity fell 11.7%, signaling significant operational challenges despite some balance sheet deleveraging. The company appears to be burning through equity value despite revenue growth, creating urgent questions about expense management and operational efficiency.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
-186.6%
$32.1M-$27.8M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Net Income
P&L
-47.4%
-$47.7M-$70.3M

Net income declined 47.4% — review whether driven by operations, interest costs, or non-recurring items.

Interest Expense
P&L
-26.4%
$39.8M$29.3M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Total Debt
Balance Sheet
-17.1%
$443.4M$367.5M

Debt reduced 17.1% — deleveraging strengthens balance sheet and reduces financial risk.

Cash & Equivalents
Balance Sheet
-14%
$168.7M$145.0M

Cash decreased 14% — monitor burn rate and upcoming capital needs.

Gross Profit
P&L
+13.1%
$256.9M$290.5M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Inventory
Balance Sheet
+13.1%
$264.8M$299.4M

Inventory built 13.1% — monitor whether demand supports this build or if write-downs may follow.

Operating Cash Flow
Cash Flow
-11.8%
$47.3M$41.7M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Stockholders Equity
Balance Sheet
-11.7%
$535.1M$472.6M

Equity decreased 11.7% — buybacks or losses reducing book value, monitor solvency ratios.

LANGUAGE CHANGES
NEW — 2025-11-18
PRIOR — 2024-11-19
ADDED
As of November 11, 2025, there were 41.7 million shares of the registrant s common stock outstanding.
Statements concerning legislative, tariff, and trade wars and trade policy reforms, responsive retaliatory actions by affected countries, government investigations, and the uncertainty resulting therefrom; geopolitical tensions; supply chain and logistics challenges; cost increases and expense management; changes in U.S.
Our products are sold in three geographic regions: the Americas, EMEA, and APAC.
Industrial In our Industrial segment, we design, develop, manufacture, sell, and service X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals.
We also manufacture and sell our own X-ray imaging systems for industrial applications.
+7 more — sign up free →
REMOVED
As of November 14, 2024, there were 41.1 million shares of the registrant s common stock outstanding.
Statements concerning supply chain and logistics challenges; cost increases and expense management; changes in U.S.
In China, the government has continued its efforts to broaden the availability of healthcare services.
Dental radiology equipment increased nine-fold, and mammography and CT scanners showed a nearly five-fold increase.
In March 2024, China introduced a new stimulus program that includes the healthcare industry.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →